Search

everythinglearnresearchcommunity

for

Search:↓

Growth factors and cytokines are important for hair growth and could potentially treat hair loss, but more research is needed to overcome challenges before they can be used in treatments.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Topical JAK inhibitors may help treat some skin conditions but need more research.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

Substance from human umbilical cord blood cells promotes hair growth.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Baricitinib is an effective treatment for severe alopecia areata.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

TNFα inhibitors are effective and well-tolerated for treating severe scalp cellulitis.

Scalp psoriasis inflammation is mainly caused by bacteria-related triggers.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Stress-related hair loss was reversed with a special medication.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

HDAC inhibitors, like Vorinostat and Entinostat, can help regrow hair in alopecia areata.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Extracts from Tridax procumbens L. have strong anti-inflammatory and antioxidant effects and block inflammation-causing enzymes.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

Cilostazol helps hair grow by making hair root cells grow faster and changing growth factor levels.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.